Home LiteratureArticle Details
PMID: 7515187 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice.

Guerder S, Picarella DE, Linsley PS, Flavell RA

Abstract

Tolerance to peripheral antigens is thought to result from the inability of parenchymal tissue to stimulate T cells--an inability that is believed to relate to the lack of expression of the costimulatory signal(s) required for T-cell activation. To test this model, we generated transgenic mice expressing costimulatory molecule B7-1 on the B cells of the pancreas. We find that islets from these transgenic mice are immunogenic for naive T cells in vitro and in vivo. Nonetheless, mice expressing the costimulator B7-1 specifically on beta cells do not develop diabetes, suggesting that expression of the B7-1 costimulator is not sufficient to abrogate the tolerance to peripheral antigens. We have reported that tumor necrosis factor alpha subunit (TNF-alpha) expressed by beta cells leads to a local inflammation but no islet destruction. Strikingly, however, the combination of a local inflammation due to the expression of the cytokine TNF-alpha and the expression of B7-1 results in tissue destruction and diabetes.

MeSH Terms
Animals Antigen-Presenting Cells/immunology Autoimmunity B7-1 Antigen/genetics,immunology Diabetes Mellitus, Type 1/immunology Humans Immunohistochemistry Islets of Langerhans/immunology Mice Mice, Inbred C57BL Mice, Inbred CBA Mice, Transgenic T-Lymphocytes/immunology Tumor Necrosis Factor-alpha/immunology
Chemicals
B7-1 Antigen Tumor Necrosis Factor-alpha
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Guerder S
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510.
Picarella D E
Linsley P S
Flavell R A
References (46)
46 references, click to expand
  1. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
    Science. 1992 Aug 7;257(5071):789-92 PMID: 1323143
  2. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.
    Nature. 1992 Apr 16;356(6370):607-9 PMID: 1313950
  3. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
    J Immunol. 1992 Nov 15;149(10):3217-24 PMID: 1385518
  4. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas.
    Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10036-40 PMID: 1279667
  5. B cells turn off virgin but not memory T cells.
    Science. 1992 Nov 13;258(5085):1156-9 PMID: 1439825
  6. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
    J Immunol. 1992 Dec 15;149(12):3802-8 PMID: 1281187
  7. Physiological and molecular mechanisms of lymphocyte homing.
    Annu Rev Immunol. 1992;10:561-91 PMID: 1590996
  8. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.
    J Exp Med. 1992 Dec 1;176(6):1719-31 PMID: 1460428
  9. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.
    Cell. 1992 Dec 24;71(7):1093-102 PMID: 1335364
  10. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.
    Science. 1993 Jan 15;259(5093):368-70 PMID: 7678351
  11. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice.
    J Immunol. 1993 May 1;150(9):4136-50 PMID: 7682590
  12. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.
    Am J Pathol. 1993 Apr;142(4):1029-40 PMID: 7682758
  13. Induction of type I diabetes by interferon-alpha in transgenic mice.
    Science. 1993 Jun 25;260(5116):1942-6 PMID: 8100367
  14. B70 antigen is a second ligand for CTLA-4 and CD28.
    Nature. 1993 Nov 4;366(6450):76-9 PMID: 7694153
  15. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.
    Science. 1993 Nov 5;262(5135):905-7 PMID: 7694361
  16. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Science. 1993 Nov 5;262(5135):907-9 PMID: 7694362
  17. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Science. 1993 Nov 5;262(5135):909-11 PMID: 7694363
  18. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3137-41 PMID: 7512724
  19. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    J Immunol. 1982 Feb;128(2):823-7 PMID: 6274961
  20. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
    J Exp Med. 1976 May 1;143(5):1283-8 PMID: 1083422
  21. Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice.
    Transplantation. 1983 Jan;35(1):62-7 PMID: 6823693
  22. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.
    Immunol Rev. 1983;74:29-56 PMID: 6195085
  23. Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells.
    Diabetes. 1985 Nov;34(11):1205-9 PMID: 3930327
  24. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept.
    Annu Rev Immunol. 1983;1:143-73 PMID: 6443557
  25. The assignment of chain specificities for anti-Ia monoclonal antibodies using L cell transfectants.
    J Immunol. 1986 Nov 1;137(9):3002-5 PMID: 3463623
  26. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells.
    Cell. 1988 Apr 8;53(1):159-68 PMID: 2964908
  27. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells.
    Nature. 1988 Jun 9;333(6173):529-33 PMID: 3287175
  28. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
    J Immunol. 1988 Oct 1;141(7):2407-12 PMID: 3139757
  29. Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV40 T antigen by using in-frame deletion mutants and a synthetic peptide.
    J Immunol. 1988 Oct 15;141(8):2734-9 PMID: 2459227
  30. Antigen presenting function of class II MHC expressing pancreatic beta cells.
    Nature. 1988 Dec 1;336(6198):476-9 PMID: 3143077
  31. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
    Proc Natl Acad Sci U S A. 1989 Feb;86(4):1333-7 PMID: 2465550
  32. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant.
    Science. 1989 Jun 9;244(4909):1179-83 PMID: 2499048
  33. Tolerance of class I histocompatibility antigens expressed extrathymically.
    Nature. 1989 Jun 22;339(6226):622-4 PMID: 2786608
  34. A cell culture model for T lymphocyte clonal anergy.
    Science. 1990 Jun 15;248(4961):1349-56 PMID: 2113314
  35. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma.
    Nature. 1990 Aug 30;346(6287):844-7 PMID: 2118234
  36. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Science. 1990 Aug 24;249(4971):918-21 PMID: 2392683
  37. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.
    J Exp Med. 1991 Mar 1;173(3):721-30 PMID: 1847722
  38. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    J Exp Med. 1991 Mar 1;173(3):759-62 PMID: 1847724
  39. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.
    Cell. 1991 Apr 19;65(2):293-304 PMID: 1849799
  40. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
    Cell. 1991 Apr 19;65(2):305-17 PMID: 1901764
  41. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.
    Cell. 1991 Apr 19;65(2):319-31 PMID: 1901765
  42. CTLA-4 is a second receptor for the B cell activation antigen B7.
    J Exp Med. 1991 Sep 1;174(3):561-9 PMID: 1714933
  43. The cell biology of antigen processing and presentation.
    Annu Rev Immunol. 1991;9:707-44 PMID: 1910692
  44. Interleukin-2, autotolerance, and autoimmunity.
    Adv Immunol. 1991;50:147-235 PMID: 1950796
  45. T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2985-9 PMID: 1532662
  46. Autoimmune diabetes as a consequence of locally produced interleukin-2.
    Nature. 1992 Oct 8;359(6395):547-9 PMID: 1406974
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-05-24
Pages
5138-42
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC43947
Subset
IM
Grants
NIDDK NIH HHS · P01-DK43078 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]